The role of the ground-glass opacity ratio in resected lung adenocarcinoma

被引:33
作者
Huang, Tsai-Wang [1 ]
Lin, Kuan-Hsun [1 ]
Huang, Hsu-Kai [1 ]
Chen, Yi-I [1 ]
Ko, Kai-Hsiung [2 ]
Chang, Cheng-Kuang [2 ]
Hsu, Hsian-He [2 ]
Chang, Hung [1 ]
Lee, Shih-Chun [1 ]
机构
[1] Natl Def Med Ctr, Div Thorac Surg, Dept Surg, Triserv Gen Hosp, Taipei, Taiwan
[2] Natl Def Med Ctr, Dept Radiol, Triserv Gen Hosp, Taipei, Taiwan
关键词
Lung cancer; Ground-glass opacity; Surgery; WHOLE TUMOR SIZE; COMPUTED-TOMOGRAPHY; SUBLOBAR RESECTION; ONCOLOGIC OUTCOMES; LYMPH-NODES; STAGE-I; CANCER; LOBECTOMY; GEFITINIB; SURVIVAL;
D O I
10.1093/ejcts/ezy040
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
OBJECTIVES: The goal of this study was to investigate the role of the ground-glass opacity (GGO) ratio in lung adenocarcinoma in predicting surgical outcomes. METHODS: Patients who underwent surgical resection for pulmonary adenocarcinoma between January 2004 and December 2013 were reviewed. The clinical data, imaging characteristics of nodules, surgical approaches and outcomes were analysed with a mean follow-up of 87 months. RESULTS: Of 789 enrolled patients, 267 cases were categorized as having a GGO ratio >= 0.75; 522 cases were categorized as having a GGO ratio <0.75. The gender, tumour differentiation, epidermal growth factor receptor mutation, smoking habits, lymphovascular space invasion, tumour size, maximum standard uptake value and carcinoembryonic antigen levels were significantly different in the 2 groups. In the group with a GGO ratio >= 0.75, 63.3% of the patients underwent sublobar resection (18.8% with a GGO ratio <0.75, P < 0.001). These patients had fewer relapses (2.2% for GGO ratio >= 0.75, 26.8% for GGO ratio <0.75, P < 0.001) and a better 5-year survival rate (95.5% for GGO ratio >= 0.75, 77.4% for GGO ratio <0.75, P < 0.001). None of the patients with a GGO ratio >= 0.75 had lymph node involvement. The multivariable Cox regression analysis revealed that a GGO ratio <0.75 was an independent factor for postoperative relapse with a hazard ratio of 3.96. CONCLUSIONS: A GGO ratio >= 0.75 provided a favourable prognostic prediction in patients with resected lung adenocarcinoma. Sublobar resection and lymph node sampling revealed a fair outcome regardless of tumour size. However, anatomical resection is still the standard approach for patients with tumours with a GGO ratio <0.75, size >2 cm.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 27 条
[1]
Results of the Two Incidence Screenings in the National Lung Screening Trial [J].
Aberle, Denise R. ;
DeMello, Sarah ;
Berg, Christine D. ;
Black, William C. ;
Brewer, Brenda ;
Church, Timothy R. ;
Clingan, Kathy L. ;
Duan, Fenghai ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine A. ;
Gierada, David S. ;
Jain, Amanda ;
Jones, Gordon C. ;
Mahon, Irene ;
Marcus, Pamela M. ;
Rathmell, Joshua M. ;
Sicks, JoRean .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10) :920-931
[2]
The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival [J].
Cerfolio, RJ ;
Bryant, AS ;
Ohja, B ;
Bartolucci, AA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (01) :151-159
[3]
Risk factors of postoperative recurrences in patients with clinical stage I NSCLC [J].
Chen, Ying-Yi ;
Huang, Tsai-Wang ;
Tsai, Wen-Chiuan ;
Lin, Li-Fan ;
Cheng, Jian-Bo ;
Chang, Hung ;
Lee, Shih-Chun .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
[4]
CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis [J].
Cheng, Zenghui ;
Shan, Fei ;
Yang, Yuesong ;
Shi, Yuxin ;
Zhang, Zhiyong .
BMC MEDICAL IMAGING, 2017, 17
[5]
Long-Term Outcomes of Wedge Resection for Pulmonary Ground-Glass Opacity Nodules [J].
Cho, Jong Ho ;
Choi, Yong Soo ;
Kim, Jhingook ;
Kim, Hong Kwan ;
Zo, Jae Ill ;
Shim, Young Mog .
ANNALS OF THORACIC SURGERY, 2015, 99 (01) :218-223
[6]
Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer? [J].
De Zoysa, Maya K. ;
Hamed, Dima ;
Routledge, Tom ;
Scarci, Marco .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (06) :816-820
[7]
Significance of the number of positive lymph nodes in resected non-small cell lung cancer [J].
Fukui, Takayuki ;
Mori, Shoichi ;
Yokoi, Kohei ;
Mitsudomi, Tetsuya .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) :120-125
[8]
Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer. [J].
Gazdar, Adi F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :1018-1020
[9]
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J].
Goldstraw, Peter ;
Crowley, John ;
Chansky, Kari ;
Giroux, Dorothy J. ;
Groome, Patti A. ;
Rami-Porta, Ramon ;
Postmus, Pieter E. ;
Rusch, Valerie ;
Sobin, Leslie .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :706-714
[10]
CT screening for lung cancer - Significance of diagnoses in its baseline cycle [J].
Henschke, CI ;
Shaham, D ;
Yankelevitz, DF ;
Kramer, A ;
Kostis, WJ ;
Reeves, AP ;
Vazquez, M ;
Koizumi, J ;
Miettinen, OS .
CLINICAL IMAGING, 2006, 30 (01) :11-15